CA19-9-negative pancreatic cancer mimicking renal cancer.
作者信息
Muraishi O, Kinebuchi Y, Ogawa A
机构信息
Department of Urology, Shinshu University School of Medicine, Matsumoto, Japan.
出版信息
Br J Urol. 1996 May;77(5):757-8.
PMID:8689132
Abstract
摘要
相似文献
1
CA19-9-negative pancreatic cancer mimicking renal cancer.
Br J Urol. 1996 May;77(5):757-8.
2
The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Eur J Surg Oncol. 2005 Mar;31(2):164-9. doi: 10.1016/j.ejso.2004.09.007.
3
CA 19-9 in pancreatic cancer.
Surg Oncol Clin N Am. 1998 Jan;7(1):93-101.
4
Is CA 19-9 a screening marker?
Dig Liver Dis. 2009 May;41(5):325-7. doi: 10.1016/j.dld.2009.02.009. Epub 2009 Mar 17.
5
[A case of transitional cell carcinoma of renal pelvis with extremely high serum levels of CA19-9 and CEA].
Hinyokika Kiyo. 1997 Jul;43(7):495-9.
6
[Late pancreatic metastasis from primary Grawitz tumor--surgical management].
Chirurgia (Bucur). 2009 Jan-Feb;104(1):105-7.
7
Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
Hepatobiliary Pancreat Dis Int. 2007 Dec;6(6):641-5.
8
A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
Am J Gastroenterol. 1999 Jul;94(7):1941-6. doi: 10.1111/j.1572-0241.1999.01234.x.
9
Individualizing therapy for pancreatic cancer.
J Gastroenterol Hepatol. 2008 Dec;23(12):1779-82. doi: 10.1111/j.1440-1746.2008.05683.x.
10
Tumor M2-pyruvate kinase as tumor marker in exocrine pancreatic cancer a meta-analysis.
Pancreas. 2007 Aug;35(2):114-9. doi: 10.1097/mpa.0b013e3180537237.
Zotero 插件